Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.

Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.

Item
http://www.wikidata.org/entity/Q36273352
Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Pilot study of the association of the DDAH2 -449G polymorphism with asymmetric dimethylarginine and hemodynamic shock in pediatric sepsis.Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.Evaluation of asymmetric dimethylarginine, arginine, and carnitine metabolism in pediatric sepsis.Impact of the L-arginine-Nitric Oxide Pathway and Oxidative Stress on the Pathogenesis of the Metabolic SyndromeHomocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.Asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia.Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.Nitric oxide and asymmetric dimethyl arginine (ADMA) levels in an experimental hydronephrotic kidney caused by unilateral partial ureteral obstruction.Continuous therapy with transdermal nitroglycerin does not affect biomarkers of vascular inflammation and injury in healthy volunteers.How does spa treatment affect cardiovascular function and vascular endothelium in patients with generalized osteoarthritis? A pilot study through plasma asymmetric di-methyl arginine (ADMA) and L-arginine/ADMA ratio.Increased asymmetric dimethylarginine concentrations in stimulated peripheral blood mononuclear cells.Oxidative stress in the pathogenesis of systemic scleroderma: An overview.
P2860

Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.

Item
http://www.wikidata.org/entity/Q36273352
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Elevated levels of asymmetric ...... ascular disease and mortality.
@ast
Elevated levels of asymmetric ...... ascular disease and mortality.
@en
type
label
Elevated levels of asymmetric ...... ascular disease and mortality.
@ast
Elevated levels of asymmetric ...... ascular disease and mortality.
@en
prefLabel
Elevated levels of asymmetric ...... ascular disease and mortality.
@ast
Elevated levels of asymmetric ...... ascular disease and mortality.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Elevated levels of asymmetric ...... ascular disease and mortality.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698